chr10-110781370-C-T

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The NM_001134363.3(RBM20):​c.761C>T​(p.Ser254Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000284 in 1,551,718 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00013 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

RBM20
NM_001134363.3 missense

Scores

4
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 2.46
Variant links:
Genes affected
RBM20 (HGNC:27424): (RNA binding motif protein 20) This gene encodes a protein that binds RNA and regulates splicing. Mutations in this gene have been associated with familial dilated cardiomyopathy. [provided by RefSeq, Apr 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.11154574).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000131 (20/152370) while in subpopulation AFR AF= 0.000409 (17/41588). AF 95% confidence interval is 0.00026. There are 1 homozygotes in gnomad4. There are 8 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 20 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RBM20NM_001134363.3 linkuse as main transcriptc.761C>T p.Ser254Leu missense_variant 2/14 ENST00000369519.4 NP_001127835.2
RBM20XM_017016103.3 linkuse as main transcriptc.596C>T p.Ser199Leu missense_variant 2/14 XP_016871592.1
RBM20XM_017016104.3 linkuse as main transcriptc.377C>T p.Ser126Leu missense_variant 2/14 XP_016871593.1
RBM20XM_047425116.1 linkuse as main transcriptc.377C>T p.Ser126Leu missense_variant 2/14 XP_047281072.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RBM20ENST00000369519.4 linkuse as main transcriptc.761C>T p.Ser254Leu missense_variant 2/141 NM_001134363.3 ENSP00000358532 P1

Frequencies

GnomAD3 genomes
AF:
0.000131
AC:
20
AN:
152252
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000325
AC:
5
AN:
153878
Hom.:
0
AF XY:
0.0000367
AC XY:
3
AN XY:
81664
show subpopulations
Gnomad AFR exome
AF:
0.000505
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000231
GnomAD4 exome
AF:
0.0000172
AC:
24
AN:
1399348
Hom.:
0
Cov.:
32
AF XY:
0.0000188
AC XY:
13
AN XY:
690186
show subpopulations
Gnomad4 AFR exome
AF:
0.000506
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000280
Gnomad4 SAS exome
AF:
0.0000126
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000371
Gnomad4 OTH exome
AF:
0.0000345
GnomAD4 genome
AF:
0.000131
AC:
20
AN:
152370
Hom.:
1
Cov.:
32
AF XY:
0.000107
AC XY:
8
AN XY:
74516
show subpopulations
Gnomad4 AFR
AF:
0.000409
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000663
Hom.:
0
Bravo
AF:
0.000136
ExAC
AF:
0.0000424
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Dilated cardiomyopathy 1DD Uncertain:1Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 25, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsAug 09, 2021- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 25, 2022Variant summary: RBM20 c.761C>T (p.Ser254Leu) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 3.2e-05 in 153878 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.761C>T has been reported in the literature in at least one individual without clinical information. This report does not provide unequivocal conclusions about association of the variant with Dilated Cardiomyopathy. Co-occurrences with a pathogenic variant has been reported (TTR c.424G>A, p.Val142Ile), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 10, 2023The p.S254L variant (also known as c.761C>T), located in coding exon 2 of the RBM20 gene, results from a C to T substitution at nucleotide position 761. The serine at codon 254 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
17
DANN
Uncertain
0.98
Eigen
Benign
-0.51
Eigen_PC
Benign
-0.52
FATHMM_MKL
Benign
0.23
N
M_CAP
Uncertain
0.20
D
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-0.38
T
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.8
N
REVEL
Benign
0.23
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.022
D
Vest4
0.14
MVP
0.46
ClinPred
0.065
T
GERP RS
4.5
gMVP
0.20

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs766868824; hg19: chr10-112541128; API